SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Apricus Biosciences
An SI Board Since September 2014
Posts SubjectMarks Bans Symbol
2026 18 0 APRI
Emcee:  mokelumne river Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1301Needed to save some money to pay for our European vacation next month MR :)phoenix_rising-6/15/2015
1300Only 15K? You may need to up your shooters. ; )mokelumne river-6/15/2015
1299From what i recall, it is a 4 week trial, so this means completion of testing miphoenix_rising-6/15/2015
1298Great news Eman...i didn't see anything about this on SA or PR from the compphoenix_rising-6/15/2015
1297good news on Rayva - Apricus Biosciences Announces Last Patient Enrolled in Raeico20-6/15/2015
1296I probably bought some of those! :P No interest, no volume, no news...let'sphoenix_rising-6/11/2015
1295Sorry to break the monotony, but short interest rose about 44K shares to 2,709,5mokelumne river-6/11/2015
1294RPRX review for Androxal set for Nov.3,2015oldcoach19-6/8/2015
1293Femprox being non-systemic but much more direct, definitely increases blood floweico20-6/6/2015
1292The other issue is that viagra increases blood flow to the genitals, but was stiphoenix_rising-6/6/2015
1291that's correct PR, APRI wanted to sell just EU rights to Femprox and keep USeico20-6/6/2015
1290I don't believe any big pharma will partner for Europe unless they get a sliphoenix_rising-6/6/2015
1289Ok, when you put it that way MR... :)phoenix_rising-6/5/2015
1288I totally agree with you Jameseico20-6/5/2015
1287PR I disagree with you and several others on ihub. It would have been inapproprmokelumne river-6/5/2015
1286Apart from the small bump at start of trading, no real interest after the flib vphoenix_rising-6/5/2015
1285you're welcome, The FDA is set to make a final decision in August, and whileeico20-6/4/2015
1284Good news indeed, after reading the new scientist article, i was having doubts. phoenix_rising-6/4/2015
1283I agree James, and the approval is what will get the ball rolling in terms of PReico20-6/4/2015
1282It will be interesting to read the press releases. I expect Pascoe, et al, to mokelumne river-6/4/2015
1281thanks james, it was fascinating to listen all day, and a tense voteeico20-6/4/2015
1280Great work, Eman!mokelumne river-6/4/2015
1279I was worried about the alcohol, but the side effects aren't dangerous, and eico20-6/4/2015
1278Vote is out - 18 yes with REMS, 6 no so their is a concensuseico20-6/4/2015
1277Eman, thanks for following the FDA meeting and especially the commentary. That mokelumne river-6/4/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News